Abstract:Purpose: Idiopathic rapid eye movement sleep behavior disorder (iRBD) is the prodromal marker of alpha-synuclein degeneration with markedly high predictive value. We aim to evaluate the value of electroencephalography (EEG) data during rapid eye movement (REM) sleep and subjective RBD severity in predicting the conversion to neurodegenerative diseases in iRBD patients. Methods: At the baseline, iRBD patients underwent clinical assessment and video-polysomnography (PSG). Relative spectral power for nine frequency bands during phasic and tonic REM sleep in three regions of interest, slow-to-fast ratios, clinical and PSG variables were estimated and compared between iRBD patients who converted to neurodegenerative diseases (iRBD-C) and iRBD patients who remained disease-free (iRBD-NC). Receiver operating characteristic (ROC) curves evaluated the predictive performance of slow-tofast ratios, and subjective RBD severity as assessed with RBD Questionnaire-Hong Kong. Results: Twenty-two (33.8%) patients eventually developed neurodegenerative diseases. The iRBD-C group showed shorter total sleep time (p < 0.001), lower stage 2 sleep percentage (p = 0.044), more periodic leg-movement-related arousal index (p = 0.004), increased tonic chin electromyelographic activity (p = 0.040) and higher REM density in the third REM episode (p = 0.034) than the iRBD-NC group. EEG spectral power analyses revealed that iRBD phenoconverters showed significantly higher delta and lower alpha power, especially in central and occipital regions during the phasic REM state compared to the iRBD-NC group. Significantly higher slow-to-fast ratios were observed in a more generalized way during the phasic state in the iRBD-C group compared to the iRBD-NC group. ROC analyses of the slowing ratio in occipital areas during phasic REM sleep yielded an area under the curve of 0.749 (p = 0.001), while no significant predictive value of subjective RBD severity was observed. Conclusion: Our study shows that EEG slowing, especially in a more generalized manner during the phasic period, may be a promising marker in predicting phenoconversion in iRBD, rather than subjective RBD severity.

Rapid Eye Movement Sleep Behavior Disorder As a Predicting Phenomenon of Α-Synucleinopathies( Report of 1 Case)

Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Diseases: An Update

Rapid Eye Movement Sleep Behavior Disorder in Patients with Probable Alzheimer’s Disease

Functional Neuroimaging in Idiopathic Rapid Eye Movement Sleep Behavior Disorder

Alterations of Brain Structural Network in Parkinson’s Disease with and Without Rapid Eye Movement Sleep Behavior Disorder

Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease

Different Patterns of Exosomal Α‐synuclein Between Parkinson's Disease and Probable Rapid Eye Movement Sleep Behavior Disorder

RBD and Neurodegenerative Diseases.

Abnormalities of Resting-State Electroencephalographic Microstate in Rapid Eye Movement Sleep Behavior Disorder

Retinal Nerve Fiber Layer Thinning: a Window into Rapid Eye Movement Sleep Behavior Disorders in Parkinson’s Disease

Reading the mind in the eyes in patients with idiopathic REM sleep behavior disorder

Clinical Biomarkers of Neurodegeneration in REM Sleep Behavior Disorder

Generalized EEG Slowing Across Phasic REM Sleep, Not Subjective RBD Severity, Predicts Neurodegeneration in Idiopathic RBD

Impaired Ocular Tracking and Cortical Atrophy in Idiopathic Rapid Eye Movement Sleep Behavior Disorder

Clinical Significance of REM Sleep Behavior Disorders and Other Non-motor Symptoms of Parkinsonism

Radionuclide Functional and Molecular Imaging in Rapid Eye Movement Sleep Behavior Disorder

Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases

Abnormal Baseline Brain Activity in Parkinson's Disease with and Without REM Sleep Behavior Disorder: A Resting‐state Functional MRI Study

A retrospective study on rapid eye movement sleep behavior disorder in Parkinson's disease

REM Sleep Behaviour Disorder: Prodromal and Mechanistic Insights for Parkinson's Disease

Advances in early predictors for phenotypic transformation of idiopathic rapid eye movement sleep behavior disorder